LONDON and REDWOOD CITY, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company” or the “Group,” a clinical stage biopharmaceutical company focused on rare diseases, today announces that it will release interim financial results for the six months ended June 30, 2019 on Tuesday, September 17, 2019. Following the release of the financial results, Mereo’s management team will host a conference call beginning at 8:30 a.m. EDT / 1:30 p.m. BST on Tuesday, September 17, 2019 to discuss the results and provide a corporate update.
Conference Call Details
Date: Tuesday, September 17, 2019
Time: 8:30 a.m. EDT / 1:30 p.m. BST
Dial-in numbers: (866) 688-2942 (U.S.) or (561) 569-9224 (U.K./International)
Conference ID number: 4572478
A live and archived webcast may be accessed by visiting the Investors sections of the Company’s website at https://www.mereobiopharma.com/news-and-events/events-and-conferences. The archived webcast will remain available on the Company's website for fourteen (14) days following the live call.
About Mereo BioPharma
Mereo BioPharma is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates for rare diseases that have already received significant investment from pharmaceutical and large biotechnology companies and that have substantial preclinical, clinical and manufacturing data packages. Mereo's existing portfolio consists of six clinical stage product candidates.
Further Enquiries
Mereo | +44 (0)333 023 7300 |
Denise Scots-Knight, Chief Executive Officer | |
Richard Jones, Chief Financial Officer | |
Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker to Mereo) | +44 (0)20 7894 7000 |
Phil Davies | |
Will Goode | |
FTI Consulting (Public Relations Adviser to Mereo) | |
Simon Conway | +44 (0)20 3727 1000 |
Brett Pollard | |
Ciara Martin | |
Burns McClellan (US Public Relations Adviser to Mereo) | +01 (0) 212 213 0006 |
Lisa Burns | |
Steve Klass |